Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 918-139-9 | CAS number: 1228577-90-9
Endpoint summary
Administrative data
Description of key information
28-day oral (gavage) NOAEL for both sexes was concluded as 40 mg/kg b.w./d ( based on nominal) based on histopathological changes in the liver and thyroids.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 40 mg/kg bw/day
Additional information
A 28-day oral (gavage) repeated dose toxicity study following the OECD guideline 407 is available for the endpoint.Starting from 160 mg/kg b.w. day histopathological changes in the liver and thyroid were observed.
The NOAEL for both sexes was concluded as 40 mg/kg b.w./d ( based on nominal).
Repeated dose toxicity: inhalation - systemic effects (target organ) digestive: liver; glandular: thyroids
Justification for classification or non-classification
According to Regulation (EC) No 1272/2008, Annex I, chapter 3.9 classification of Diaminotoluene, propoxylated as STOT RE cat. 2 is not recommended.
Although the LOAEL (160 mg/kg) is below the guidance value for 28-day studies (300 mg/kg), the nature and severity of the adverse effects at this dose level do not support classification.
Hematological changes at 160 mg/kg (females) and even at 640 mg/kg (females/males) give no conclusive evidence of consistent and significant adverse effect in hematology.
The periportal hepatocellular changes observed at 160 mg/kg (2/5 males and 5/5 females grade 2) and even at 640 mg/kg (5/5 male and 5/5 female, grade 3) give no evidence of multifocal or diffuse necrosis, fibrosis or granuloma formation. The morphological alterations comply with those typical for reversible hepatic changes due to liver enzymes induction reflecting increased metabolism and hepatic clearance of Diaminotoluene, propoxylated. The follicular cell hyperthrophy/hyperplasie in the thyroids, observed in both genders up to a moderate degree at 160 mg/kg (grade 2) and 640 mg/kg (grade 3), are interpreted as being a specific thyroid toxicity via liver enzyme induction.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
